@col69 Yes its definitely high tide for the whole executive company officers, collectively they have been quite reactive and without urgency. Surely they could engage with Surgcentre for a partnership with regards to CHF. Lets be entirely honest Mesoblast has lost a fair amount of bargaining dividend and the market understands the challenges and business friction they have endured over several years. A partnership will also prove advantageous as a credit raise is just around the corner and the 60 million shorts are waiting for this in eager anticipation, but at what discount and dilution? versus offset CR to a partnership deal which like many shareholders would rather see a discount to partner than another discount to shorters, Times up for MSB to start acring commercial and being more assertive in their dealings, again balance between technical and business acumen.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-16849
-
- There are more pages in this discussion • 972 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.21 |
Change
0.020(1.68%) |
Mkt cap ! $1.370B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.18 | $1.815M | 1.522M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 76567 | $1.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.22 | 57926 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 26990 | 1.195 |
13 | 44342 | 1.190 |
12 | 122374 | 1.185 |
10 | 70499 | 1.180 |
10 | 135779 | 1.175 |
Price($) | Vol. | No. |
---|---|---|
1.200 | 244598 | 29 |
1.205 | 97591 | 7 |
1.210 | 70622 | 11 |
1.215 | 35581 | 8 |
1.220 | 62449 | 6 |
Last trade - 10.53am 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |